Skip to Main Content
  • About
    • Staff
    • Board of Directors
    • Member Directory
  • Membership
    • Membership Benefits
    • Membership FAQ
    • Join NEC
  • Issues
    • Diversity & Inclusion
    • Energy & Environment
    • Financial Services
    • Healthcare
    • Higher Education
    • Housing
    • Technology & Innovation
    • Trade
    • Transportation & Infrastructure
    • Partnerships for Talent Pipeline Directory
  • News
  • Events
    • Upcoming Events
    • Past Events
    • 2025 Centennial Celebration
    • Washington Leaders’ Conference
    • Politics & Eggs
    • Inside the Corner Office
    • Rising Stars Network
    • Celebrating 100 Years
      • New England Council Fellows Program
    • Sponsorship Opportunities
  • Contact
  • About
    • Staff
    • Board of Directors
    • Member Directory
  • Membership
    • Membership Benefits
    • Membership FAQ
    • Join NEC
  • Issues
    • Diversity & Inclusion
    • Energy & Environment
    • Financial Services
    • Healthcare
    • Higher Education
    • Housing
    • Technology & Innovation
    • Trade
    • Transportation & Infrastructure
    • Partnerships for Talent Pipeline Directory
  • News
  • Events
    • Upcoming Events
    • Past Events
    • 2025 Centennial Celebration
    • Washington Leaders’ Conference
    • Politics & Eggs
    • Inside the Corner Office
    • Rising Stars Network
    • Celebrating 100 Years
      • New England Council Fellows Program
    • Sponsorship Opportunities
  • Contact

News

Mar 29, 2021Blog | Member News

Bristol Myers Squibb Expands Devens Facility for Cancer Research

Devens building under construction
Image from www.wbjournal.com

NEC member Bristol Myers Squibb, a New York-based biopharmaceutical company, recently added a 244,000 square-foot expansion to their Devens, MA, facility to further the company’s efforts to battle cancer. The new addition is expected to begin operations by the end of the year and will be at the forefront of cancer technology for producing Breyanzi, a CAR-T cell therapy designed to treat lymphoma in patients.

CAR-T cell therapy is a highly specialized process involving genetically modified cells that are personalized to attack a patient’s cancer cells. It generally takes weeks to isolate, freeze, dilute, and monitor the modified cells before the patient can receive an infusion. Though Breyanzi only recently won FDA approval in February 2021 and is a relatively new technology, the Devens expansion seeks to enhance CAR-T cell manufacturing capability for Bristol Myers-Squibb. The site is also expected to add hundreds of jobs.

Krishnan Viswanadhan, a senior vice president for the company’s global cell therapy franchise, stated, “I’m really excited about what cell therapy has to offer.”

The New England Council congratulates Bristol Myers Squibb on their expansion and looks forward to seeing continuous advancements in cell research in the fight against cancer. Read more from the Worcester Business Journal.

Council Related News
Read Article Blog | Member News, Energy & Environment

Dominion Energy Charitable Foundation awards grants to 352 Nonprofits

Read Article Blog | Member News, Higher Education

University of New England announces partnership with Atlantic Hospitality to advance student careers

Read Article Blog | Member News, Higher Education

A study released by the CCIC reveals independent colleges are vital to the state’s economy

Read Article Blog | Member News, Energy & Environment

Unitil and Eversource Announce Water Utility Deals

Read Article Blog | Member News, Technology & Innovation

General Dynamics Electric Boat awarded $12.2 billion contract to boost shipbuilder pay and build two new submarines

View Related News

©2025 New England Council
All rights reserved.

Privacy Policy Website Design by Jackrabbit

Boston Office

98 North Washington Street
Suite 303
Boston, MA 02114

(617) 723-4009

necouncil@newenglandcouncil.com

Washington Office

1411 K Street, NW
Suite 700
Washington, D.C. 20005

(202) 547-0048

necouncil@newenglandcouncil.com

Website Design by Jackrabbit